Picture of Hikma Pharmaceuticals logo

HIK Hikma Pharmaceuticals News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareBalancedLarge CapContrarian

REG - Hikma Pharmaceutical - Director/PDMR Shareholding <Origin Href="QuoteRef">HIK.L</Origin>

RNS Number : 3429E
Hikma Pharmaceuticals Plc
08 February 2018

Hikma Pharmaceuticals PLC

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Said Darwazah

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Said Darwazah

2

Reason for the notification

a)

Position/status

Chairman and Chief Executive Officer / PDMR

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each

ID Code: GB00B0LCW083

b)

Nature of the transaction

Release of a pledge by Darhold Limited over 2,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Europe Arab Bank Plc. The Chairman and Chief Executive is a director of and shareholder in Darhold Limited with an equity interest of 21.67%.

c)

Price(s) and volume(s)

Price(s): 0.00p

Volume(s): 2,000,000

d)

Aggregated information

Aggregated volume: 2,000,000

Price: 0.00p

e)

Date of the transaction

7 December 2017

f)

Place of the transaction

Amman

Mazen Darwazah

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mazen Darwazah

2

Reason for the notification

a)

Position/status

Executive Vice Chairman / PDMR

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each

ID Code: GB00B0LCW083

b)

Nature of the transaction

Release of a pledge by Darhold Limited over 2,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Europe Arab Bank Plc. The Executive Vice Chairman is a director of and shareholder in Darhold Limited with an equity interest of 10.92%.

c)

Price(s) and volume(s)

Price(s): 0.00p

Volume(s): 2,000,000

d)

Aggregated information

Aggregated volume: 2,000,000

Price: 0.00p

e)

Date of the transaction

7 December 2017

f)

Place of the transaction

Amman

Mohammed 'Ali' Al-Husry

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mohammed 'Ali' Al-Husry

2

Reason for the notification

a)

Position/status

Non-Executive Director/ PDMR

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each

ID Code: GB00B0LCW083

b)

Nature of the transaction

Release of a pledge by Darhold Limited over 2,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Europe Arab Bank Plc. The Non-Executive Director is a director of and shareholder in Darhold Limited with an equity interest of 8.01%.

c)

Price(s) and volume(s)

Price(s): 0.00p

Volume(s): 2,000,000

d)

Aggregated information

Aggregated volume: 2,000,000

Price: 0.00p

e)

Date of the transaction

7 December 2017

f)

Place of the transaction

Amman


This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBDGDDIXGBGII

Recent news on Hikma Pharmaceuticals

See all news